APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-Malarial Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Anti-Malarial Drug Industry Growth and Trends Forecast to 2032

20 December 2025100 pages

Choose your research edition.

Industry ResearchAnti-Malarial Drug Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-Malarial Drug Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Anti-Malarial Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-Malarial Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-Malarial Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Anti-Malarial Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Anti-Malarial Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Anti-Malarial Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-Malarial Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-Malarial Drug include Alvizia, F. Hoffmann-La Roche, Ipca, Ranbaxy, Zydus Cadila, Bayer, GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Anti-Malarial Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Anti-Malarial Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Malarial Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Malarial Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Anti-Malarial Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Anti-Malarial Drug Market by Company

Alvizia

F. Hoffmann-La Roche

Ipca

Ranbaxy

Zydus Cadila

Bayer

GlaxoSmithKline

Pfizer

Merck

Novartis

Anti-Malarial Drug Segment by Type

Plasmodium Falciparum

Plasmodium Vivax

Plasmodium Ovale

Plasmodium Malariae

Anti-Malarial Drug Segment by Application

E-Commerce

Retail Pharmacy

Hospital Pharmacy

Others

Anti-Malarial Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Malarial Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-Malarial Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Malarial Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-Malarial Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Anti-Malarial Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Plasmodium Falciparum Table 2. Major Company of Plasmodium Vivax Table 3. Major Company of Plasmodium Ovale Table 4. Major Company of Plasmodium Malariae Table 5. Global Anti-Malarial Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Anti-Malarial Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Anti-Malarial Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Anti-Malarial Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Anti-Malarial Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Anti-Malarial Drug Price by Type (2021-2026) & (US$/Unit) Table 11. Global Anti-Malarial Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Anti-Malarial Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Anti-Malarial Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Anti-Malarial Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Anti-Malarial Drug Price by Type (2027-2032) & (US$/Unit) Table 16. North America Anti-Malarial Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Anti-Malarial Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Anti-Malarial Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Anti-Malarial Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Anti-Malarial Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Anti-Malarial Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Anti-Malarial Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Anti-Malarial Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Anti-Malarial Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Anti-Malarial Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Anti-Malarial Drug Industry Trends Table 27. Anti-Malarial Drug Industry Drivers Table 28. Anti-Malarial Drug Industry Opportunities and Challenges Table 29. Anti-Malarial Drug Industry Restraints Table 30. Global Anti-Malarial Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Anti-Malarial Drug Revenue Market Share by Company (2021-2026) Table 32. Global Anti-Malarial Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Anti-Malarial Drug Sales Share by Company (2021-2026) Table 34. Global Anti-Malarial Drug Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Anti-Malarial Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Anti-Malarial Drug Major Company Production Sites and Headquarters Table 37. Global Anti-Malarial Drug Company, Product Type & Application Table 38. Global Anti-Malarial Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Anti-Malarial Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Anti-Malarial Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Anti-Malarial Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Anti-Malarial Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Anti-Malarial Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Anti-Malarial Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Anti-Malarial Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Anti-Malarial Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Anti-Malarial Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Anti-Malarial Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Anti-Malarial Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Anti-Malarial Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Anti-Malarial Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Anti-Malarial Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Anti-Malarial Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Anti-Malarial Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Anti-Malarial Drug Price by Application (2021-2026) & (US$/Unit) Table 58. Global Anti-Malarial Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Anti-Malarial Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Anti-Malarial Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Anti-Malarial Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Anti-Malarial Drug Price by Application (2027-2032) & (US$/Unit) Table 63. North America Anti-Malarial Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Anti-Malarial Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Anti-Malarial Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Anti-Malarial Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Anti-Malarial Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Anti-Malarial Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Anti-Malarial Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Anti-Malarial Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Anti-Malarial Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Anti-Malarial Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Alvizia Company Information Table 74. Alvizia Business Overview Table 75. Alvizia Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Alvizia Anti-Malarial Drug Product Portfolio Table 77. Alvizia Recent Development Table 78. F. Hoffmann-La Roche Company Information Table 79. F. Hoffmann-La Roche Business Overview Table 80. F. Hoffmann-La Roche Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolio Table 82. F. Hoffmann-La Roche Recent Development Table 83. Ipca Company Information Table 84. Ipca Business Overview Table 85. Ipca Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Ipca Anti-Malarial Drug Product Portfolio Table 87. Ipca Recent Development Table 88. Ranbaxy Company Information Table 89. Ranbaxy Business Overview Table 90. Ranbaxy Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Ranbaxy Anti-Malarial Drug Product Portfolio Table 92. Ranbaxy Recent Development Table 93. Zydus Cadila Company Information Table 94. Zydus Cadila Business Overview Table 95. Zydus Cadila Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Zydus Cadila Anti-Malarial Drug Product Portfolio Table 97. Zydus Cadila Recent Development Table 98. Bayer Company Information Table 99. Bayer Business Overview Table 100. Bayer Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Bayer Anti-Malarial Drug Product Portfolio Table 102. Bayer Recent Development Table 103. GlaxoSmithKline Company Information Table 104. GlaxoSmithKline Business Overview Table 105. GlaxoSmithKline Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. GlaxoSmithKline Anti-Malarial Drug Product Portfolio Table 107. GlaxoSmithKline Recent Development Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Pfizer Anti-Malarial Drug Product Portfolio Table 112. Pfizer Recent Development Table 113. Merck Company Information Table 114. Merck Business Overview Table 115. Merck Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Merck Anti-Malarial Drug Product Portfolio Table 117. Merck Recent Development Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis Anti-Malarial Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Novartis Anti-Malarial Drug Product Portfolio Table 122. Novartis Recent Development Table 123. North America Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 124. North America Anti-Malarial Drug Sales by Country (2021-2026) & (K Units) Table 125. North America Anti-Malarial Drug Sales Market Share by Country (2021-2026) Table 126. North America Anti-Malarial Drug Sales Forecast by Country (2027-2032) & (K Units) Table 127. North America Anti-Malarial Drug Sales Market Share Forecast by Country (2027-2032) Table 128. North America Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Anti-Malarial Drug Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Anti-Malarial Drug Market Share by Country (2021-2026) Table 131. North America Anti-Malarial Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Anti-Malarial Drug Market Share Forecast by Country (2027-2032) Table 133. Europe Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 134. Europe Anti-Malarial Drug Sales by Country (2021-2026) & (K Units) Table 135. Europe Anti-Malarial Drug Sales Market Share by Country (2021-2026) Table 136. Europe Anti-Malarial Drug Sales Forecast by Country (2027-2032) & (K Units) Table 137. Europe Anti-Malarial Drug Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Anti-Malarial Drug Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Anti-Malarial Drug Market Share by Country (2021-2026) Table 141. Europe Anti-Malarial Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Anti-Malarial Drug Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Anti-Malarial Drug Sales by Country (2021-2026) & (K Units) Table 145. Asia-Pacific Anti-Malarial Drug Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Anti-Malarial Drug Sales Forecast by Country (2027-2032) & (K Units) Table 147. Asia-Pacific Anti-Malarial Drug Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Anti-Malarial Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Anti-Malarial Drug Market Share by Country (2021-2026) Table 151. Asia-Pacific Anti-Malarial Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Anti-Malarial Drug Market Share Forecast by Country (2027-2032) Table 153. Latin America Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Latin America Anti-Malarial Drug Sales by Country (2021-2026) & (K Units) Table 155. Latin America Anti-Malarial Drug Sales Market Share by Country (2021-2026) Table 156. Latin America Anti-Malarial Drug Sales Forecast by Country (2027-2032) & (K Units) Table 157. Latin America Anti-Malarial Drug Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Anti-Malarial Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Anti-Malarial Drug Market Share by Country (2021-2026) Table 161. Latin America Anti-Malarial Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Anti-Malarial Drug Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Anti-Malarial Drug Sales by Country (2021-2026) & (K Units) Table 165. Middle East and Africa Anti-Malarial Drug Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Anti-Malarial Drug Sales Forecast by Country (2027-2032) & (K Units) Table 167. Middle East and Africa Anti-Malarial Drug Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Anti-Malarial Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Anti-Malarial Drug Market Share by Country (2021-2026) Table 171. Middle East and Africa Anti-Malarial Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Anti-Malarial Drug Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Anti-Malarial Drug Distributors List Table 176. Anti-Malarial Drug Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Anti-Malarial Drug Image Figure 2. Global Anti-Malarial Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-Malarial Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-Malarial Drug Sales (2021-2032) & (K Units) Figure 5. Plasmodium Falciparum Image Figure 6. Global Plasmodium Falciparum Sales YoY Growth (2021-2032) & (K Units) Figure 7. Plasmodium Vivax Image Figure 8. Global Plasmodium Vivax Sales YoY Growth (2021-2032) & (K Units) Figure 9. Plasmodium Ovale Image Figure 10. Global Plasmodium Ovale Sales YoY Growth (2021-2032) & (K Units) Figure 11. Plasmodium Malariae Image Figure 12. Global Plasmodium Malariae Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Anti-Malarial Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Anti-Malarial Drug Market Share by Type 2025 VS 2032 Figure 15. North America Anti-Malarial Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Anti-Malarial Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Anti-Malarial Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Anti-Malarial Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Anti-Malarial Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Anti-Malarial Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Anti-Malarial Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Anti-Malarial Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Anti-Malarial Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Anti-Malarial Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Anti-Malarial Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. E-Commerce Image Figure 28. Global E-Commerce Sales YoY Growth (2021-2032) & (K Units) Figure 29. Retail Pharmacy Image Figure 30. Global Retail Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 31. Hospital Pharmacy Image Figure 32. Global Hospital Pharmacy Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Anti-Malarial Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Anti-Malarial Drug Market Share by Application 2025 VS 2032 Figure 37. North America Anti-Malarial Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Anti-Malarial Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Anti-Malarial Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Anti-Malarial Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Anti-Malarial Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Anti-Malarial Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Anti-Malarial Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Anti-Malarial Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Anti-Malarial Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Anti-Malarial Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Anti-Malarial Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Anti-Malarial Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Anti-Malarial Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Anti-Malarial Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Anti-Malarial Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Anti-Malarial Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Anti-Malarial Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Anti-Malarial Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Anti-Malarial Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Anti-Malarial Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Anti-Malarial Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Anti-Malarial Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Anti-Malarial Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Anti-Malarial Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Anti-Malarial Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Anti-Malarial Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Anti-Malarial Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Anti-Malarial Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Anti-Malarial Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Anti-Malarial Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Anti-Malarial Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Anti-Malarial Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Plasmodium Ovale
  • Plasmodium Malariae
Applications
  • E-Commerce
  • Retail Pharmacy
  • Hospital Pharmacy
  • Others
Companies covered
  • Alvizia
  • F. Hoffmann-La Roche
  • Ipca
  • Ranbaxy
  • Zydus Cadila
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Anti-Malarial Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Anti-Malarial Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Anti-Malarial Drug Market by Type
  6. 1.3.1 Plasmodium Falciparum
  7. 1.3.2 Plasmodium Vivax
  8. 1.3.3 Plasmodium Ovale
  9. 1.3.4 Plasmodium Malariae
  10. 1.4 Global Anti-Malarial Drug Market Size by Type
  11. 1.4.1 Global Anti-Malarial Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Anti-Malarial Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Anti-Malarial Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Anti-Malarial Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Anti-Malarial Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Anti-Malarial Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Anti-Malarial Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Anti-Malarial Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Anti-Malarial Drug Industry Trends
  2. 2.2 Anti-Malarial Drug Industry Drivers
  3. 2.3 Anti-Malarial Drug Industry Opportunities and Challenges
  4. 2.4 Anti-Malarial Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Anti-Malarial Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Anti-Malarial Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Anti-Malarial Drug Price (2021-2026)
  4. 3.4 Global Anti-Malarial Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-Malarial Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Anti-Malarial Drug Company, Product Type & Application
  7. 3.7 Global Anti-Malarial Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-Malarial Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-Malarial Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-Malarial Drug Tier 1, Tier 2, and Tier 3
4 Anti-Malarial Drug Regional Status and Outlook
  1. 4.1 Global Anti-Malarial Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Anti-Malarial Drug Historic Market Size by Region
  3. 4.2.1 Global Anti-Malarial Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Anti-Malarial Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Anti-Malarial Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Anti-Malarial Drug Forecasted Market Size by Region
  7. 4.3.1 Global Anti-Malarial Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Anti-Malarial Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Anti-Malarial Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Malarial Drug by Application
  1. 5.1 Anti-Malarial Drug Market by Application
  2. 5.1.1 E-Commerce
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Anti-Malarial Drug Market Size by Application
  7. 5.2.1 Global Anti-Malarial Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Anti-Malarial Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Anti-Malarial Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Anti-Malarial Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Anti-Malarial Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Anti-Malarial Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Anti-Malarial Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Anti-Malarial Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alvizia
  2. 6.1.1 Alvizia Company Information
  3. 6.1.2 Alvizia Business Overview
  4. 6.1.3 Alvizia Anti-Malarial Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alvizia Anti-Malarial Drug Product Portfolio
  6. 6.1.5 Alvizia Recent Developments
  7. 6.2 F. Hoffmann-La Roche
  8. 6.2.1 F. Hoffmann-La Roche Company Information
  9. 6.2.2 F. Hoffmann-La Roche Business Overview
  10. 6.2.3 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 F. Hoffmann-La Roche Anti-Malarial Drug Product Portfolio
  12. 6.2.5 F. Hoffmann-La Roche Recent Developments
  13. 6.3 Ipca
  14. 6.3.1 Ipca Company Information
  15. 6.3.2 Ipca Business Overview
  16. 6.3.3 Ipca Anti-Malarial Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Ipca Anti-Malarial Drug Product Portfolio
  18. 6.3.5 Ipca Recent Developments
  19. 6.4 Ranbaxy
  20. 6.4.1 Ranbaxy Company Information
  21. 6.4.2 Ranbaxy Business Overview
  22. 6.4.3 Ranbaxy Anti-Malarial Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Ranbaxy Anti-Malarial Drug Product Portfolio
  24. 6.4.5 Ranbaxy Recent Developments
  25. 6.5 Zydus Cadila
  26. 6.5.1 Zydus Cadila Company Information
  27. 6.5.2 Zydus Cadila Business Overview
  28. 6.5.3 Zydus Cadila Anti-Malarial Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zydus Cadila Anti-Malarial Drug Product Portfolio
  30. 6.5.5 Zydus Cadila Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Anti-Malarial Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Anti-Malarial Drug Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 GlaxoSmithKline
  38. 6.7.1 GlaxoSmithKline Company Information
  39. 6.7.2 GlaxoSmithKline Business Overview
  40. 6.7.3 GlaxoSmithKline Anti-Malarial Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline Anti-Malarial Drug Product Portfolio
  42. 6.7.5 GlaxoSmithKline Recent Developments
  43. 6.8 Pfizer
  44. 6.8.1 Pfizer Company Information
  45. 6.8.2 Pfizer Business Overview
  46. 6.8.3 Pfizer Anti-Malarial Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Pfizer Anti-Malarial Drug Product Portfolio
  48. 6.8.5 Pfizer Recent Developments
  49. 6.9 Merck
  50. 6.9.1 Merck Company Information
  51. 6.9.2 Merck Business Overview
  52. 6.9.3 Merck Anti-Malarial Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck Anti-Malarial Drug Product Portfolio
  54. 6.9.5 Merck Recent Developments
  55. 6.10 Novartis
  56. 6.10.1 Novartis Company Information
  57. 6.10.2 Novartis Business Overview
  58. 6.10.3 Novartis Anti-Malarial Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis Anti-Malarial Drug Product Portfolio
  60. 6.10.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Anti-Malarial Drug Sales by Country
  2. 7.1.1 North America Anti-Malarial Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Anti-Malarial Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Anti-Malarial Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Anti-Malarial Drug Market Size by Country
  6. 7.2.1 North America Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Anti-Malarial Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Anti-Malarial Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Anti-Malarial Drug Sales by Country
  2. 8.1.1 Europe Anti-Malarial Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Anti-Malarial Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Anti-Malarial Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Anti-Malarial Drug Market Size by Country
  6. 8.2.1 Europe Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Anti-Malarial Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Anti-Malarial Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Anti-Malarial Drug Sales by Country
  2. 9.1.1 Asia-Pacific Anti-Malarial Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Anti-Malarial Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Anti-Malarial Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Anti-Malarial Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Anti-Malarial Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Anti-Malarial Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Anti-Malarial Drug Sales by Country
  2. 10.1.1 South America Anti-Malarial Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Anti-Malarial Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Anti-Malarial Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Anti-Malarial Drug Market Size by Country
  6. 10.2.1 South America Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Anti-Malarial Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Anti-Malarial Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Anti-Malarial Drug Sales by Country
  2. 11.1.1 Middle East and Africa Anti-Malarial Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Anti-Malarial Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Anti-Malarial Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Anti-Malarial Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Anti-Malarial Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Anti-Malarial Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Anti-Malarial Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Anti-Malarial Drug Value Chain Analysis
  2. 12.1.1 Anti-Malarial Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Anti-Malarial Drug Production Mode & Process
  7. 12.2 Anti-Malarial Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Anti-Malarial Drug Distributors
  10. 12.2.3 Anti-Malarial Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst